Filters
Filters

 

Resource Type
Topic
Show (105)
Cancel
Discovery of KNa1.1 channel inhibitors – an account of Metrion’s first webinar
July 21, 2021
Read More
The Ionic Inspiration of Venomtech – by Steve Trim
July 21, 2021
Read More
Metrion Biosciences appoints Mark Keogh as Non-Executive Director
April 19, 2021
Read More
Metrion Biosciences closes £2.7m new equity financing
April 6, 2021
Read More
The Drug Discovery for Ion Channels XXII Satellite Meeting
March 4, 2021
Read More
Metrion Biosciences appoints John Montana as Non-Executive Director
February 9, 2021
Read More
Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration
February 1, 2021
Read More
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
January 18, 2021
Read More
SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels
January 5, 2021
Read More
Charlotte’s Patch Clamp Journey So Far…
November 9, 2020
Read More
1 … 4 5 6 7 8 … 11
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram